Evidence map›Paper›PMID 17170456›Full record

ArticleThe Journal of general virology2007

OTK18, a zinc-finger protein, regulates human immunodeficiency virus type 1 long terminal repeat through two distinct regulatory regions.

Masahide Horiba, Lindsey B Martinez, James L Buescher, Shinji Sato, Jenae Limoges, Yunquan Jiang, Clinton Jones, Tsuneya Ikezu

Abstract read
In one paragraph

Article in The Journal of general virology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.6field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Apobec3A maintains HIV-1 latency through recruitment of epigenetic silencing machinery to the long terminal repeat.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Molecular Understanding of HIV-1 Latency.Advances in virology · 2012
    Article
  9. Gypsy and the birth of the SCAN domain.Journal of virology · 2011
    Article
  10. Article
  11. Review
  12. Calpain and proteasomal regulation of antiretroviral zinc finger protein OTK18 in human macrophages: visualization in live cells by intramolecular FRET.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2009
    Article
  13. YY1 and FoxD3 regulate antiretroviral zinc finger protein OTK18 promoter activation induced by HIV-1 infection.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2009
    Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Masahide HoribaDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5880, USA.
Lindsey B MartinezDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5880, USA.
James L BuescherDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5880, USA.
Shinji SatoDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5880, USA.
Jenae LimogesDepartment of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198-5880, USA.
Yunquan JiangDepartment of Veterinary and Biomedical Sciences, University of Nebraska, Lincoln, NE 68583-0905, USA.
Clinton JonesDepartment of Veterinary and Biomedical Sciences, University of Nebraska, Lincoln, NE 68583-0905, USA.
Tsuneya IkezuDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5880, USA.
University of Nebraska Medical Center · USUniversity of Nebraska–Lincoln · US

Funding

VIRAL SHUTOFF OF HOST TRANSCRIPTION--PBCV-1 INFECTEDP20RR015635 · NCRR · UNIVERSITY OF NEBRASKA LINCOLN · PI WOOD, CHARLES · 2000 to 2009
$22.1M
OTK18 Regulation in HIV-1 associated dementiaR01MH072539 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI IKEZU, TSUNEYA · 2005 to 2009
$1.2M
AntiRetroviral Activities of NEBRIR01AI050894 · NIAID · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI IKEZU, TSUNEYA · 2001 to 2003
$442k
NCRR NIH HHS P20 RR015635NCRR NIH HHS P20RR15635NIAID NIH HHS R01 AI050894NIAID NIH HHS R01 AI5089401NIMH NIH HHS MH01532NIMH NIH HHS R01 MH072539
6 · The paper itself

Abstract

It has previously been shown by our laboratory that OTK18, a human immunodeficiency virus (HIV)-inducible zinc-finger protein, reduces progeny-virion production in infected human macrophages. OTK18 antiviral activity is mediated through suppression of Tat-induced HIV-1 long terminal repeat (LTR) promoter activity. Through the use of LTR-scanning mutant vectors, the specific regions responsible for OTK18-mediated LTR suppression have been defined. Two different LTR regions were identified as potential OTK18-binding sites by an enhanced DNA-transcription factor ELISA system; the negative-regulatory element (NRE) at -255/-238 and the Ets-binding site (EBS) at -150/-139 in the LTR. In addition, deletion of the EBS in the LTR blocked OTK18-mediated LTR suppression. These data indicate that OTK18 suppresses LTR activity through two distinct regulatory elements. Spontaneous mutations in these regions might enable HIV-1 to escape from OTK18 antiretroviral activity in human macrophages.

Indexed as

DNA-Binding ProteinsDNA, ViralGene Expression Regulation, ViralHIV-1HIV Long Terminal RepeatHumansTranscription FactorsTranscription, GeneticDNA-Binding ProteinsDNA, ViralTranscription FactorsZNF175 protein, human

Identifiers

PMID17170456
PMCPMC3229096
OpenAlexW2085489774

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.